Cargando…

Human Fecal Microbiota Transplantation Reduces the Susceptibility to Dextran Sulfate Sodium-Induced Germ-Free Mouse Colitis

In clinical practice, fecal microbiota transplantation (FMT) has been used to treat inflammatory bowel disease (IBD), and has shown certain effects. However, the selection of FMT donors and the mechanism underlying the effect of FMT intervention in IBD require further exploration. In this study, dex...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yapeng, Zheng, Xiaojiao, Wang, Yuqing, Tan, Xiang, Zou, Huicong, Feng, Shuaifei, Zhang, Hang, Zhang, Zeyue, He, Jinhui, Cui, Bota, Zhang, Xueying, Wu, Zhifeng, Dong, Miaomiao, Cheng, Wei, Tao, Shiyu, Wei, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882623/
https://www.ncbi.nlm.nih.gov/pubmed/35237276
http://dx.doi.org/10.3389/fimmu.2022.836542
_version_ 1784659735732027392
author Yang, Yapeng
Zheng, Xiaojiao
Wang, Yuqing
Tan, Xiang
Zou, Huicong
Feng, Shuaifei
Zhang, Hang
Zhang, Zeyue
He, Jinhui
Cui, Bota
Zhang, Xueying
Wu, Zhifeng
Dong, Miaomiao
Cheng, Wei
Tao, Shiyu
Wei, Hong
author_facet Yang, Yapeng
Zheng, Xiaojiao
Wang, Yuqing
Tan, Xiang
Zou, Huicong
Feng, Shuaifei
Zhang, Hang
Zhang, Zeyue
He, Jinhui
Cui, Bota
Zhang, Xueying
Wu, Zhifeng
Dong, Miaomiao
Cheng, Wei
Tao, Shiyu
Wei, Hong
author_sort Yang, Yapeng
collection PubMed
description In clinical practice, fecal microbiota transplantation (FMT) has been used to treat inflammatory bowel disease (IBD), and has shown certain effects. However, the selection of FMT donors and the mechanism underlying the effect of FMT intervention in IBD require further exploration. In this study, dextran sodium sulfate (DSS)-induced colitis mice were used to determine the differences in the protection of colitis symptoms, inflammation, and intestinal barrier, by FMT from two donors. Intriguingly, pre-administration of healthy bacterial fluid significantly relieved the symptoms of colitis compared to the ulcerative colitis (UC) bacteria. In addition, healthy donor (HD) bacteria significantly reduced the levels of inflammatory markers Myeloperoxidase (MPO) and Eosinophil peroxidase (EPO), and various pro-inflammatory factors, in colitis mice, and increased the secretion of the anti-inflammatory factor IL-10. Metagenomic sequencing indicated higher species diversity and higher abundance of anti-inflammatory bacteria in the HD intervention group, including Alistipes putredinis, Akkermansia muciniphila, Bifidobacterium adolescentis, short-chain fatty acids (SCFAs)-producing bacterium Christensenella minuta, and secondary bile acids (SBAs)-producing bacterium Clostridium leptum. In the UC intervention group, the SCFA-producing bacterium Bacteroides stercoris, IBD-related bacterium Ruminococcus gnavus, Enterococcus faecalis, and the conditional pathogen Bacteroides caccae, were more abundant. Metabolomics analysis showed that the two types of FMT significantly modulated the metabolism of DSS-induced mice. Moreover, compared with the UC intervention group, indoleacetic acid and unsaturated fatty acids (DHA, DPA, and EPA) with anti-inflammatory effects were significantly enriched in the HD intervention group. In summary, these results indicate that FMT can alleviate the symptoms of colitis, and the effect of HD intervention is better than that of UC intervention. This study offers new insights into the mechanisms of FMT clinical intervention in IBD.
format Online
Article
Text
id pubmed-8882623
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88826232022-03-01 Human Fecal Microbiota Transplantation Reduces the Susceptibility to Dextran Sulfate Sodium-Induced Germ-Free Mouse Colitis Yang, Yapeng Zheng, Xiaojiao Wang, Yuqing Tan, Xiang Zou, Huicong Feng, Shuaifei Zhang, Hang Zhang, Zeyue He, Jinhui Cui, Bota Zhang, Xueying Wu, Zhifeng Dong, Miaomiao Cheng, Wei Tao, Shiyu Wei, Hong Front Immunol Immunology In clinical practice, fecal microbiota transplantation (FMT) has been used to treat inflammatory bowel disease (IBD), and has shown certain effects. However, the selection of FMT donors and the mechanism underlying the effect of FMT intervention in IBD require further exploration. In this study, dextran sodium sulfate (DSS)-induced colitis mice were used to determine the differences in the protection of colitis symptoms, inflammation, and intestinal barrier, by FMT from two donors. Intriguingly, pre-administration of healthy bacterial fluid significantly relieved the symptoms of colitis compared to the ulcerative colitis (UC) bacteria. In addition, healthy donor (HD) bacteria significantly reduced the levels of inflammatory markers Myeloperoxidase (MPO) and Eosinophil peroxidase (EPO), and various pro-inflammatory factors, in colitis mice, and increased the secretion of the anti-inflammatory factor IL-10. Metagenomic sequencing indicated higher species diversity and higher abundance of anti-inflammatory bacteria in the HD intervention group, including Alistipes putredinis, Akkermansia muciniphila, Bifidobacterium adolescentis, short-chain fatty acids (SCFAs)-producing bacterium Christensenella minuta, and secondary bile acids (SBAs)-producing bacterium Clostridium leptum. In the UC intervention group, the SCFA-producing bacterium Bacteroides stercoris, IBD-related bacterium Ruminococcus gnavus, Enterococcus faecalis, and the conditional pathogen Bacteroides caccae, were more abundant. Metabolomics analysis showed that the two types of FMT significantly modulated the metabolism of DSS-induced mice. Moreover, compared with the UC intervention group, indoleacetic acid and unsaturated fatty acids (DHA, DPA, and EPA) with anti-inflammatory effects were significantly enriched in the HD intervention group. In summary, these results indicate that FMT can alleviate the symptoms of colitis, and the effect of HD intervention is better than that of UC intervention. This study offers new insights into the mechanisms of FMT clinical intervention in IBD. Frontiers Media S.A. 2022-02-14 /pmc/articles/PMC8882623/ /pubmed/35237276 http://dx.doi.org/10.3389/fimmu.2022.836542 Text en Copyright © 2022 Yang, Zheng, Wang, Tan, Zou, Feng, Zhang, Zhang, He, Cui, Zhang, Wu, Dong, Cheng, Tao and Wei https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Yang, Yapeng
Zheng, Xiaojiao
Wang, Yuqing
Tan, Xiang
Zou, Huicong
Feng, Shuaifei
Zhang, Hang
Zhang, Zeyue
He, Jinhui
Cui, Bota
Zhang, Xueying
Wu, Zhifeng
Dong, Miaomiao
Cheng, Wei
Tao, Shiyu
Wei, Hong
Human Fecal Microbiota Transplantation Reduces the Susceptibility to Dextran Sulfate Sodium-Induced Germ-Free Mouse Colitis
title Human Fecal Microbiota Transplantation Reduces the Susceptibility to Dextran Sulfate Sodium-Induced Germ-Free Mouse Colitis
title_full Human Fecal Microbiota Transplantation Reduces the Susceptibility to Dextran Sulfate Sodium-Induced Germ-Free Mouse Colitis
title_fullStr Human Fecal Microbiota Transplantation Reduces the Susceptibility to Dextran Sulfate Sodium-Induced Germ-Free Mouse Colitis
title_full_unstemmed Human Fecal Microbiota Transplantation Reduces the Susceptibility to Dextran Sulfate Sodium-Induced Germ-Free Mouse Colitis
title_short Human Fecal Microbiota Transplantation Reduces the Susceptibility to Dextran Sulfate Sodium-Induced Germ-Free Mouse Colitis
title_sort human fecal microbiota transplantation reduces the susceptibility to dextran sulfate sodium-induced germ-free mouse colitis
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882623/
https://www.ncbi.nlm.nih.gov/pubmed/35237276
http://dx.doi.org/10.3389/fimmu.2022.836542
work_keys_str_mv AT yangyapeng humanfecalmicrobiotatransplantationreducesthesusceptibilitytodextransulfatesodiuminducedgermfreemousecolitis
AT zhengxiaojiao humanfecalmicrobiotatransplantationreducesthesusceptibilitytodextransulfatesodiuminducedgermfreemousecolitis
AT wangyuqing humanfecalmicrobiotatransplantationreducesthesusceptibilitytodextransulfatesodiuminducedgermfreemousecolitis
AT tanxiang humanfecalmicrobiotatransplantationreducesthesusceptibilitytodextransulfatesodiuminducedgermfreemousecolitis
AT zouhuicong humanfecalmicrobiotatransplantationreducesthesusceptibilitytodextransulfatesodiuminducedgermfreemousecolitis
AT fengshuaifei humanfecalmicrobiotatransplantationreducesthesusceptibilitytodextransulfatesodiuminducedgermfreemousecolitis
AT zhanghang humanfecalmicrobiotatransplantationreducesthesusceptibilitytodextransulfatesodiuminducedgermfreemousecolitis
AT zhangzeyue humanfecalmicrobiotatransplantationreducesthesusceptibilitytodextransulfatesodiuminducedgermfreemousecolitis
AT hejinhui humanfecalmicrobiotatransplantationreducesthesusceptibilitytodextransulfatesodiuminducedgermfreemousecolitis
AT cuibota humanfecalmicrobiotatransplantationreducesthesusceptibilitytodextransulfatesodiuminducedgermfreemousecolitis
AT zhangxueying humanfecalmicrobiotatransplantationreducesthesusceptibilitytodextransulfatesodiuminducedgermfreemousecolitis
AT wuzhifeng humanfecalmicrobiotatransplantationreducesthesusceptibilitytodextransulfatesodiuminducedgermfreemousecolitis
AT dongmiaomiao humanfecalmicrobiotatransplantationreducesthesusceptibilitytodextransulfatesodiuminducedgermfreemousecolitis
AT chengwei humanfecalmicrobiotatransplantationreducesthesusceptibilitytodextransulfatesodiuminducedgermfreemousecolitis
AT taoshiyu humanfecalmicrobiotatransplantationreducesthesusceptibilitytodextransulfatesodiuminducedgermfreemousecolitis
AT weihong humanfecalmicrobiotatransplantationreducesthesusceptibilitytodextransulfatesodiuminducedgermfreemousecolitis